NYSE · ESE

ESCO Technologies, Inc.

$327.78 -$3.63 (-1.10%) 1D Market open
Charting by TradingView

Key Metrics

$8.59B
Market cap
27.86×
P/E · TTM
$1.18B
Revenue · TTM
$308.14M
Net income
EPS · TTM $11.89
Dividend yield 0.1%
Free cash flow $224.84M
Beta · 1Y 1.07
EBITDA · TTM $235.83M
Gross margin —

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 27
    Money has been moving out of its sector (Technology).

    Technology has run -4.1 points vs SPY over four weeks, ranking 8→2→11→7 of 11 sectors — this stock trades inside that current.

    RECEIPT: ROTATION MAP, LIVE ↗
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 8
    The stock moved -8.9% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 8

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$8.59B
Enterprise value$8.64B
Shares outstanding25.9M
52-wk range$174.92 – $362.15
Avg volume · 20D136.3K
Net cash −$52.75M
Book value / share$61.19
IndustryCommunications Equipment, Nec
ExchangeNYSE
About ESCO Technologies, Inc.
IPO dateOct 19, 1990
Employees3425

ESCO Technologies Inc sells engineered products and systems for utility, industrial, aerospace, and commercial applications. The firm operates in three segments: Aerospace & Defense (A&D), Utility Solutions Group (USG), and RF Test & Measurement (Test).

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E27.86
P/S7.26
P/FCF38.19
EV/EBITDA36.63
EV/Sales7.31
Graham №$127.96

Profitability

Gross —
Operating 13.7%
Net 26.1%
FCF 19.0%
ROE / ROIC 21.8% · 7.6%

Financial Health

Current ratio1.45
Quick ratio0.98
Debt / equity0.09
Debt / EBITDA 0.61Low leverage
Net cash −$52.75M
Working capital$226.43M

Cash Flow · TTM

Operating CF $258.95M
Capex −$34.11M
Free cash flow $224.84M
Buybacks —
Dividends paid $8.28M
Shareholder yield 0.1%

Piotroski F-Score

3 / 9
Weak fundamentals · 3 of 9 signals passing

Altman Z-Score

7.9
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$127.96 vs $327.78
Trades 2.6× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings